CIBC Private Wealth Group
NAUT icon

CIBC Private Wealth Group’s Nautilus Biotechnolgy NAUT Stock Holding History

CIBC Private Wealth Group’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$364 – 3211
2024
Q4 		$364 Hold
200
– – ﹤0.01% 2871
2024
Q3 		$570 Hold
200
– – ﹤0.01% 2961
2024
Q2 		$456 Hold
200
– – ﹤0.01% 2987
2024
Q1 		$600 Buy
+200
New +$567 ﹤0.01% 2918

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

CIBC Private Wealth Group's NAUT Position: Q1 2025 in Review

CIBC Private Wealth Group sold out of Nautilus Biotechnolgy (NAUT) in Q1 2025, closing a stake of 200 shares — an estimated $364 sold.

CIBC Private Wealth Group first reported a position in NAUT in Q1 2024 and held it in 4 quarters. The position peaked at $600 in Q1 2024. 88 funds tracked by Wall St. Rank hold NAUT as of Q1 2025.

  • CIBC Private Wealth Group reported no remaining Nautilus Biotechnolgy position as of Q1 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 200 Nautilus Biotechnolgy shares in Q1 2025, an estimated $364.
  • CIBC Private Wealth Group first reported a position in Nautilus Biotechnolgy in Q1 2024 and held it in 4 quarters.
  • CIBC Private Wealth Group's Nautilus Biotechnolgy position peaked at $600 in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2025.

Based on CIBC Private Wealth Group's 13F filing for Q1 2025, filed 14 May 2025.